Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship

Although a monoclonal antibody targeting the multifunctional ectoenzyme CD38 is an FDA-approved drug, few small molecule inhibitors exist for this enzyme that catalyzes inter alia the formation and metabolism of the <i>N</i>1-ribosylated, Ca<sup>2+</sup>-mobilizing, second me...

Full description

Bibliographic Details
Main Authors: Joanna M. Watt, Richard Graeff, Barry V. L. Potter
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/23/7165
_version_ 1797507372732645376
author Joanna M. Watt
Richard Graeff
Barry V. L. Potter
author_facet Joanna M. Watt
Richard Graeff
Barry V. L. Potter
author_sort Joanna M. Watt
collection DOAJ
description Although a monoclonal antibody targeting the multifunctional ectoenzyme CD38 is an FDA-approved drug, few small molecule inhibitors exist for this enzyme that catalyzes inter alia the formation and metabolism of the <i>N</i>1-ribosylated, Ca<sup>2+</sup>-mobilizing, second messenger cyclic adenosine 5′-diphosphoribose (cADPR). <i>N</i>1-Inosine 5′-monophosphate (<i>N</i>1-IMP) is a fragment directly related to cADPR. 8-Substituted-<i>N</i>1-IMP derivatives, prepared by degradation of cyclic parent compounds, inhibit CD38-mediated cADPR hydrolysis more efficiently than related cyclic analogues, making them attractive for inhibitor development. We report a total synthesis of the <i>N</i>1-IMP scaffold from adenine and a small initial compound series that facilitated early delineation of structure-activity parameters, with analogues evaluated for inhibition of CD38-mediated hydrolysis of cADPR. The 5′-phosphate group proved essential for useful activity, but substitution of this group by a sulfonamide bioisostere was not fruitful. 8-NH<sub>2</sub>-<i>N</i>1-IMP is the most potent inhibitor (IC<sub>50</sub> = 7.6 μM) and importantly HPLC studies showed this ligand to be cleaved at high CD38 concentrations, confirming its access to the CD38 catalytic machinery and demonstrating the potential of our fragment approach.
first_indexed 2024-03-10T04:48:34Z
format Article
id doaj.art-a4b277117732405ca369cdbf4afde384
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T04:48:34Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-a4b277117732405ca369cdbf4afde3842023-11-23T02:48:23ZengMDPI AGMolecules1420-30492021-11-012623716510.3390/molecules26237165Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity RelationshipJoanna M. Watt0Richard Graeff1Barry V. L. Potter2Medicinal Chemistry & Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKDepartment of Physiology, University of Hong Kong, Hong Kong, ChinaMedicinal Chemistry & Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKAlthough a monoclonal antibody targeting the multifunctional ectoenzyme CD38 is an FDA-approved drug, few small molecule inhibitors exist for this enzyme that catalyzes inter alia the formation and metabolism of the <i>N</i>1-ribosylated, Ca<sup>2+</sup>-mobilizing, second messenger cyclic adenosine 5′-diphosphoribose (cADPR). <i>N</i>1-Inosine 5′-monophosphate (<i>N</i>1-IMP) is a fragment directly related to cADPR. 8-Substituted-<i>N</i>1-IMP derivatives, prepared by degradation of cyclic parent compounds, inhibit CD38-mediated cADPR hydrolysis more efficiently than related cyclic analogues, making them attractive for inhibitor development. We report a total synthesis of the <i>N</i>1-IMP scaffold from adenine and a small initial compound series that facilitated early delineation of structure-activity parameters, with analogues evaluated for inhibition of CD38-mediated hydrolysis of cADPR. The 5′-phosphate group proved essential for useful activity, but substitution of this group by a sulfonamide bioisostere was not fruitful. 8-NH<sub>2</sub>-<i>N</i>1-IMP is the most potent inhibitor (IC<sub>50</sub> = 7.6 μM) and importantly HPLC studies showed this ligand to be cleaved at high CD38 concentrations, confirming its access to the CD38 catalytic machinery and demonstrating the potential of our fragment approach.https://www.mdpi.com/1420-3049/26/23/7165synthesiscADPRcyclasenucleotidefragment
spellingShingle Joanna M. Watt
Richard Graeff
Barry V. L. Potter
Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship
Molecules
synthesis
cADPR
cyclase
nucleotide
fragment
title Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship
title_full Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship
title_fullStr Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship
title_full_unstemmed Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship
title_short Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-<i>N</i>1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship
title_sort small molecule cd38 inhibitors synthesis of 8 amino i n i 1 inosine 5 monophosphate analogues and early structure activity relationship
topic synthesis
cADPR
cyclase
nucleotide
fragment
url https://www.mdpi.com/1420-3049/26/23/7165
work_keys_str_mv AT joannamwatt smallmoleculecd38inhibitorssynthesisof8aminoini1inosine5monophosphateanaloguesandearlystructureactivityrelationship
AT richardgraeff smallmoleculecd38inhibitorssynthesisof8aminoini1inosine5monophosphateanaloguesandearlystructureactivityrelationship
AT barryvlpotter smallmoleculecd38inhibitorssynthesisof8aminoini1inosine5monophosphateanaloguesandearlystructureactivityrelationship